SCHEMBL5370893

SCHEMBL5370893

CCCCCc1c(C(N)=O)cccc1C(N)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.53
LMNA P02545 2/20 0.53
MEN1 O00255 1/20 0.53
NR1I2 O75469 1/20 0.53
CHRM2 P08172 1/20 0.53
ADRA2A P08913 1/20 0.53
MAPT P10636 1/20 0.53
OPRK1 P41145 1/20 0.53
HTR2B P41595 1/20 0.53
SLC6A3 Q01959 1/20 0.53
KMT2A Q03164 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
TSHR P16473 4/20 0.43
TP53 P04637 1/20 0.43
MAPK1 P28482 1/20 0.43
PLK1 P53350 1/20 0.42
ALDH1A1 P00352 4/20 0.42
CXCR5 P32302 1/20 0.42
BID P55957 3/20 0.41
MCL1 Q07820 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27405674 0.98 LMNA (0.55) CYP3A4LMNAMEN1NR1I2CHRM2
SCHEMBL28371050 0.98 LMNA (0.55) CYP3A4LMNAMEN1NR1I2CHRM2
SCHEMBL6535320 0.98 LMNA (0.55) CYP3A4LMNAMEN1NR1I2CHRM2
SCHEMBL2972655 0.94 LMNA (0.50) CYP3A4LMNAMEN1NR1I2CHRM2
SCHEMBL29652142 0.92 PLK1 (0.50) CYP3A4LMNAMEN1NR1I2CHRM2
SCHEMBL6720660 0.92 PLK1 (0.50) CYP3A4LMNAMEN1NR1I2CHRM2
SCHEMBL6013405 0.91 CXCR5 (0.51) CYP3A4LMNAMEN1NR1I2CHRM2
SCHEMBL10903924 0.90 CYP3A4 (0.48) CYP3A4LMNAMEN1NR1I2CHRM2
SCHEMBL6013408 0.90 LMNA (0.51) CYP3A4LMNAMEN1NR1I2CHRM2
SCHEMBL22736732 0.90 BID (0.48) CYP3A4LMNAMEN1NR1I2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1453789-A2 N,N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES Elan Pharmaceuticals, Inc. (US) 2004-09-08 EP claimed
WO-2003040096-A2 N, N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES ELAN PHARMACEUTICALS, INC. (US) 2003-05-15 WO claimed
US-7176242-B2 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives ELAN PHARMACEUTICALS, INC. (US) 2007-02-13 US disclosed